NYSE$CC
The Chemours · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Chemours' second quarter results demonstrated strength with record TSS and APM performance.
Chemours reported record net sales of $1.9 billion, up 16% year-over-year, driven by strong demand across all segments. Record Adjusted EBITDA for both TSS and APM. The company is now targeting the high end of Adjusted EBITDA guidance and increasing Free Cash Flow outlook.
- Record Net Sales of $1.9 billion, up 16% year-over-year, including record Net Sales in all three segments
- Net Income of $201 million with EPS of $1.26, up $0.87 year-over-year
- Adjusted Net Income of $302 million with Adjusted EPS of $1.89, up $0.69 year-over-year
- Adjusted EBITDA of $475 million, up 30% year-over-year
Headline financials
Revenue & EPS history
Chemours · Revenue · Quarterly
$1.92B
Forward guidance
Chemours anticipates achieving the high end of its full year Adjusted EBITDA range and are raising its cash flow outlook to greater than $600 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+1.4%
Avg return
Earnings day
+2.4%
Avg return
5 days after
+1.2%
Avg return
30 days after
55%
27 / 49 earnings
Positive
+24.2%
Q4 2019
Best reaction
-23.0%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.7% | -9.6% | -26.8% | |
| Q4 2025 | -16.5% | -11.7% | -13.3% | |
| Q3 2025 | +6.8% | +7.4% | +8.2% | |
| Q1 2025 | -9.4% | -0.9% | -8.1% | |
| Q4 2024 | +3.9% | -0.4% | -12.8% | |
| Q3 2024 | +11.6% | +11.1% | +19.4% | |
| Q2 2024 | -15.0% | -22.5% | -19.6% | |
| Q1 2024 | -6.1% | -4.0% | -7.6% | |
| Q4 2023 | -4.1% | +5.0% | -0.2% | |
| Q3 2023 | -0.1% | +2.1% | +11.7% | |
| Q2 2023 | -4.8% | -4.0% | -14.8% | |
| Q1 2023 | +6.4% | +11.1% | +4.4% | |
| Q4 2022 | -1.7% | -0.8% | -10.7% | |
| Q3 2022 | +1.0% | -0.9% | +13.5% | |
| Q2 2022 | +4.0% | +1.6% | +4.5% | |
| Q1 2022 | +17.7% | +21.1% | +31.7% | |
| Q4 2021 | -16.8% | -13.9% | -26.9% | |
| Q3 2021 | +8.0% | +4.7% | -3.0% | |
| Q2 2021 | +1.9% | +4.7% | +6.5% | |
| Q1 2021 | +4.4% | +14.7% | +23.0% | |
| Q4 2020 | -2.6% | -1.8% | +7.1% | |
| Q3 2020 | +2.2% | +8.3% | +23.0% | |
| Q2 2020 | -0.3% | +5.9% | +12.8% | |
| Q1 2020 | +12.9% | +18.3% | +44.4% | |
| Q4 2019 | +24.2% | +19.1% | -33.9% | |
| Q3 2019 | +13.9% | +13.4% | -11.1% | |
| Q2 2019 | -23.0% | -26.5% | -25.7% | |
| Q1 2019 | -1.8% | -16.4% | -39.4% | |
| Q4 2018 | -2.6% | -3.0% | -2.2% | |
| Q3 2018 | +4.1% | +2.9% | -13.7% | |
| Q2 2018 | +4.9% | +6.7% | -2.8% | |
| Q1 2018 | +4.5% | +4.4% | +1.7% | |
| Q4 2017 | +2.7% | +2.5% | +4.5% | |
| Q3 2017 | -8.4% | -10.5% | -9.0% | |
| Q2 2017 | -1.6% | +3.8% | +4.3% | |
| Q1 2017 | -1.0% | +2.4% | -0.7% | |
| Q4 2016 | -0.5% | +3.1% | +8.4% | |
| Q3 2016 | +12.7% | +21.1% | +52.3% | |
| Q2 2016 | +13.2% | +25.8% | +49.6% | |
| Q1 2015 | -3.1% | — | — | |
| Q1 2016 | +9.6% | — | — | |
| Q1 2014 | +2.3% | — | — | |
| Q4 2013 | +2.3% | — | — | |
| Q4 2015 | +14.3% | — | — | |
| Q3 2014 | -17.2% | — | — | |
| Q3 2015 | -17.2% | — | — | |
| Q4 2014 | +16.3% | — | — | |
| Q2 2014 | +16.3% | — | — | |
| Q2 2015 | +16.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro